Researchers from the National Human Genome Research Institute in Bethesda, Maryland, have further characterized a genetic risk for attention-deficit/hyperactivity disorder (ADHD).[1] Their study focused on gene variants within a previously characterized ADHD linkage region called ADGRL3.